Endpoint Health
DefunctYC W19San Francisco, US · Founded 2018 · 23 employees · 5 known investors
Find your way into Endpoint Health
2,748 people in our graph share verified history with the Endpoint Health team — schools, employers, funds. One of them is your warm intro.
Mike Zakunlockedknows Leonardo Teixeira · together at Cornell (overlapped)
×6knows the team · via Barclays
knows the team · via Cornell
knows the team · via Y Combinator
×2knows the team · via Stony Brook University
knows the team · via Cornell Johnson Graduate School of Management
Endpoint Health develops immunology-focused therapeutics paired with diagnostic tests designed to match individual patients with treatments suited to their biology for critical and chronic illnesses.
Also known as Inc.
Founders & leadership· Y Combinator alumni (W19)
Endpoint Health was founded in 2018 by Diego Rey, Jeff Osborn, Jason Springs, and Leonardo Teixeira.
DR

Diego Reyin𝕏Co-Founder & Chief Scientific Officer2018–2024Diego Rey holds degrees in electrical engineering from UC Santa Barbara and a PhD in biomedical engineering from Cornell. He co-founded GeneWEAVE, which was acquired by Roche, and Endpoint Health, focusing on bacterial detection and immune disease therapeutics.
JO

Jeff OsborninCo-Founder & Chief Technology Officer2019–2022Jeff Osborn brings over 20 years of technology and business experience across investment banking, advertising, automotive, and pharmaceutical sectors, including work in both Fortune 50 companies and as a founder. He founded Endpoint Health, which develops immunology-focused therapeutics paired with diagnostic tests to match patients with targeted treatments for critical and chronic illnesses.
JS

Jason SpringsinCo-Founder and CEO2018–2025
LT

Leonardo TeixeirainCo-Founder & COO2018–2025Leonardo Teixeira co-founded GeneWEVE, a diagnostic company acquired by Roche in 2015, where he later led a diagnostic development team in the critical care division. He is now co-founder and COO of Endpoint Health, developing precision medicine therapeutics and diagnostics for hospitalized patients.
Investors · 5
Funding
SEC filings, press & company announcements$52M disclosed across 1 of 3 rounds · 2020–2022
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Endpoint Health do?
- Endpoint Health develops immunology-focused therapeutics paired with diagnostic tests designed to match individual patients with treatments suited to their biology for critical and chronic illnesses.
- Who founded Endpoint Health?
- Endpoint Health was founded by Diego Rey, Jeff Osborn, Jason Springs, Leonardo Teixeira in 2018.
- Who are Endpoint Health's investors?
- Endpoint Health's investors include Alix Ventures, Knockout Capital, Y Combinator, AME Cloud Ventures, Boom Capital Ventures.
- How much funding has Endpoint Health raised?
- Endpoint Health has disclosed $52M raised across 1 of its 3 known rounds.
- Where is Endpoint Health headquartered?
- Endpoint Health is headquartered in San Francisco, US.




